Bum Jobs Number Boo...
Health Care: Health Services
BioMimetic Therapeutics Inc. (BMTI: NASDAQ)
$2.49 -0.03 | -1.19%
06/01/12 - 04:00 PM ET
Ratio Comparisons
| Company | Industry | S&P 500 | |
| Valuation Ratios | |||
|---|---|---|---|
| P/E Ratio (TTM) | n.a. | 15.40 | 17.70 |
| P/E High - Last 5 Yrs | n.a. | 49.90 | 67.70 |
| P/E Low - Last 5 Yrs | n.a. | 15.50 | 12.50 |
| Beta | 0.87 | 0.77 | 0.98 |
| Price to Sales (TTM) | 39.17 | 1.97 | 1.42 |
| Price to Book (MRQ) | 1.44 | 2.14 | 2.41 |
| Price to Tangible Book (MRQ) | 1.52 | 7.49 | 5.08 |
| Price to Cash Flow (TTM) | -2.30 | 10.50 | 9.80 |
| Price to Free Cash Flow (TTM) | -2.40 | 58.60 | 17.40 |
| Dividends | |||
| Dividend Yield (%) | 0.00 | 1.10 | 2.10 |
| Dividend Yield - 5 Yr Avg (%) | n.a. | 1.00 | 2.20 |
| Dividend 5 Yr Growth Rate (%) | n.a. | 8.98 | -0.76 |
| Payout Ratio (TTM) | 0.00 | 17.00 | 30.00 |
| Sales (MRQ) vs Qtr 1 Yr Ago (%) | 17.00 | 10.90 | 11.80 |
| Sales (TTM) vs TTM 1 Yr Ago (%) | 17.10 | -11.40 | 9.20 |
| Growth Rates (%) | |||
| Sales - 5 Yr Growth Rate (%) | -23.06 | 12.06 | 1.79 |
| EPS (MRQ) vs Qtr 1 Yr Ago (%) | n.a. | 8.70 | 17.50 |
| EPS (TTM) vs TTM 1 Yr Ago (%) | n.a. | 8.70 | 17.50 |
| EPS - 5 Yr Growth Rate (%) | n.a. | n.a. | -1.66 |
| Capital Spending - 5 Yr Growth Rate (%) | n.a. | 6.33 | -1.17 |
| Financial Strength | |||
| Quick Ratio (MRQ) | 13.00 | 1.80 | 1.10 |
| Current Ratio (MRQ) | 14.70 | 2.70 | 1.60 |
| LT Debt to Equity (MRQ) | 0.00 | 0.32 | 0.82 |
| Total Debt to Equity (MRQ) | 0.00 | 0.34 | 0.96 |
| Interest Coverage (TTM) | n.a. | 11.50 | 5.50 |
| Profitability Ratios (%) | |||
| Gross Margin (TTM) | 96.90 | 59.90 | 46.90 |
| Gross Margin - 5 Yr Avg | 73.10 | 59.90 | 47.70 |
| EBITD Margin (TTM) | n.a. | 23.80 | 18.90 |
| EBITD - 5 Yr Avg | -596.87 | 0.00 | 0.00 |
| Pre-Tax Margin (TTM) | n.a. | 15.40 | 12.10 |
| Pre-Tax Margin - 5 Yr Avg | n.a. | 11.90 | 10.30 |
| Management Effectiveness (%) | |||
| Net Profit Margin (TTM) | -17.49 | 0.13 | 0.09 |
| Net Profit Margin - 5 Yr Avg | n.a. | 8.70 | 7.00 |
| Return on Assets (TTM) | -46.80 | 7.60 | 3.10 |
| Return on Assets - 5 Yr Avg | -25.00 | 5.20 | 2.50 |
| Return on Investment (TTM) | -64.00 | 10.20 | 7.90 |
| Return on Investment - 5 Yr Avg | -33.10 | 7.20 | 6.50 |
| Efficiency | |||
| Revenue/Employee (TTM) | 23,902.00 | 296,359.00 | 449,376.00 |
| Net Income/Employee (TTM) | -418,052.00 | 40,294.00 | 39,003.00 |
| Receivable Turnover (TTM) | 3.30 | 6.00 | 7.60 |
| Inventory Turnover (TTM) | 0.00 | 2.90 | 8.30 |
| Asset Turnover (TTM) | 0.00 | 0.60 | 0.40 |
Portfolios with BMTI
- Portfolio NameUser Type
- ContributorStocks With Big Insider Buy...
- Usertest
- ContributorBarron's Activist Stocks 12...
- Userjcweddell Portfolio 1
- Userrazzmazz Portfolio 1
- ContributorBarron's Activist Stocks 7-...
- ContributorBarron's Insider Purchases ...
- Useramarmaharaj Portfolio 1
- UserGet this thing started
- UserBREAKOUTS2008
Latest BMTI Headlines from TheStreet
- BioMimetic Stock Hits New 52-Week Low (BMTI) 07.27.11 | 04:07 pm
- BioMimetic Stock Hits New 52-Week Low (BMTI) 07.19.11 | 12:07 pm
- BioMimetic Stock Hits New 52-Week Low (BMTI) 07.11.11 | 11:07 am
- BioMimetic Stock Hits New 52-Week Low (BMTI) 07.01.11 | 12:07 pm
- BioMimetic Stock Hits New 52-Week Low (BMTI) 06.23.11 | 11:06 am
- BioMimetic Stock Hits New 52-Week Low (BMTI) 06.08.11 | 12:06 pm
- BioMimetic Stock Falls On Unusually High Volume (BMTI) 05.13.11 | 10:05 am
- BioMimetic Stock Gaps Down On Today's Open (BMTI) 05.10.11 | 09:05 am
- Insiders Buy and Sell RealD IPO 07.20.10 | 09:07 am
- Stock Offerings: First of Long Island 07.15.10 | 09:07 am
Press Releases for BMTI
- BioMimetic Therapeutics, Inc. Reports First Quarter 2012 Earnings Results - Business Wire 05.09.12 | 04:05 pm
- BioMimetic Therapeutics, Inc. To Report First Quarter 2012 Financial Results On May 9 - Business Wire 05.07.12 | 11:05 am
- BioMimetic Therapeutics, Inc. Reports Fourth Quarter And Year-End 2011 Earnings Results - Business Wire 03.13.12 | 04:03 pm
- BioMimetic Therapeutics, Inc. To Report 2011 Fourth Quarter And Year-End Financial Results On March 13 - Business Wire 03.09.12 | 02:03 pm
- BioMimetic Therapeutics, Inc. To Introduce Augmatrix™ Biocomposite Bone Graft Product Line At AAOS - Business Wire 02.08.12 | 09:02 am
- BioMimetic Therapeutics, Inc. To Highlight Product Development Activities At ORS And AAOS Meetings - Business Wire 02.06.12 | 04:02 pm
- BioMimetic Therapeutics, Inc. To Present At The 30th Annual J.P. Morgan Healthcare Conference - Business Wire 01.10.12 | 11:01 am
- BioMimetic Therapeutics Announces Approval To Market GEM 21S® In The European Union - Business Wire 01.03.12 | 04:01 pm
- BioMimetic Therapeutics Receives Augment® Bone Graft PMA Response Letter From FDA - Business Wire 01.03.12 | 04:01 pm
- BioMimetic Therapeutics, Inc. Reports Third Quarter 2011 Earnings Results - Business Wire 11.08.11 | 04:11 pm
Partner Headlines for BMTI
- Speculative Biotech: A Speculation Trader's Dream and Nightmare - Seeking Alpha 11.03.11 | 09:11 am
- Earnings Report Card, Regenerative Medicine Universe Edition - Seeking Alpha 08.11.11 | 09:08 am
- Morning Market Losers (BMTI, NSPH, HEAT, PAL) - Benzinga 05.10.11 | 09:05 am
- 9 Healthcare Companies Expecting May Catalysts - Seeking Alpha 05.04.11 | 08:05 am
- BioMimetic: What the Bulls Are Seeing - Seeking Alpha 03.18.11 | 08:03 am
- Early-Market Movers: Vivus, Amedisys - Fox Business 07.13.10 | 09:07 am
